Gordan Srkalovic

Clinical trials

• S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

  Principal investigator · Terminated · Phase 2

  SWOG Cancer Research Network

  2005–2010
• S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia

  Study chair · Withdrawn · Phase 2

  SWOG Cancer Research Network

  2008
• Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment

  Study chair · Unknown · Phase 2

  Sparrow Regional Cancer Center

  2006
• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

  Site PI · Recruiting

  Agendia

  2017–2037